exRNAdisease

Entry Detail

---



General Information

Database ID: exR0269717 RNA Name: hsa-miR-33b-5p RNA Type: miRNA Chromosome: chr17 Starnd: - Coordinate: Start Site(bp): 17813897 End Site(bp): 17813916 External Links: hsa-miR-33b-5p

Disease Information

Disease Name: Multiple Sclerosis Disease Category: Nervous System Diseases MeSH ID: D009103 Type: Diseases Category/Nervous System Diseases Alias: Sclerosis, Multiple//Sclerosis, Disseminated//Disseminated Sclerosis//MS (Multiple Sclerosis)//Multiple Sclerosis, Acute Fulminating

Expression Detail

GEO ID: GSE140106 Description: Serum exosome microRNAs predict multiple sclerosis disease activity after fingolimod treatment Experimental Design: Fingolimod treatment Case Disease Type: Multiple Sclerosis Case Disease SubType: NA Case Sample: Fingolimod treated Multiple Sclerosis Control Sample: Untreated Number of Case: 27 Number of Control: 27 Number of Samples: 54

Regulatory Relationship

mRNA targets: Gene Symbol Chromosome Start Site(bp) End Site(bp) Strand ADCY9 chr16 3953387 4116442 - AFF4 chr5 132875395 132963634 - BTBD7 chr14 93237550 93333092 - CERK chr22 46684410 46738252 - CROT chr7 87345681 87399795 + DDX5 chr17 64498254 64508199 - E2F3 chr6 20401879 20493714 + ECHDC1 chr6 127288712 127343609 - EIF5A2 chr3 170888418 170908644 - IGF1R chr15 98648539 98964530 + IRS2 chr13 109752695 109786583 - MAPK1IP1L chr14 55051647 55070194 + MAPK6 chr15 51952106 52067375 + MTHFD2 chr2 74198610 74217565 + MYO19 chr17 36495633 36543435 - NAA15 chr4 139301505 139420033 + NFAT5 chr16 69565094 69704666 + PIM1 chr6 37170152 37175428 + RBM33 chr7 155644451 155781485 + RCAN1 chr21 34513142 34615113 - ROBO1 chr3 78597239 79767998 - SLC39A8 chr4 102251041 102431258 - SULF2 chr20 47656348 47786616 - TNPO1 chr5 72816312 72916733 + TPM1 chr15 63042632 63071915 + UBN2 chr7 139230356 139308236 + WDFY3 chr4 84669610 84966391 - XRN1 chr3 142306607 142448062 - ZFYVE16 chr5 80408013 80483379 + ZNF148 chr3 125225561 125375354 - miRNA targets: NA circRNA targets: circRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand hsa_circ_0000540 chr14 55799534 55821940 + hsa_circ_0001349 chr3 152132729 152150709 + hsa_circ_0000642 chr15 80390757 80415142 + hsa_circ_0000643 chr15 80412669 80415142 + hsa_circ_0000284 chr11 33307958 33309057 + lncRNA targets: lncRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand AC023509.1 chr12 53441741 53467528 + DANCR chr4 52712404 52720351 + FGD5-AS1 chr3 14920347 14948424 - MCF2L-AS1 chr13 112967484 112968824 - NEAT1 chr11 65422774 65445540 + Display:

Experiment Detail

GEO ID: GSE140106 Sample Source: Blood Source Fraction: Exosome Platform: GPL11154 Method: NGS Num of detected RNA Type: 1 Num of detected RNAs of this Type: 1907 Sample treatment protocol: Exosomes were isolated from 1 mL RNase A (37 °C for 10 min; 100 ng/ml; Qiagen, Australia) treated serum, by size exclusion chromatography (qEV iZONE Science). RNA Extract protocol: Serum exosomes were processed for RNA extraction using the Plasma/Serum Circulating & Exosomal RNA Purification Mini Kit (Norgen Biotek, Cat. 51000) according to the manufacturer's protocol. RNA library preparation protocol: Exosome RNA sequencing libraries were then constructed using the NEBNext Multiplex Small RNA Library Prep Kit for Illumina (BioLabs, New England) according to the manufacturer's instructions.

Reference

PMID: 31721043 Title: Serum Exosome MicroRNAs Predict Multiple Sclerosis Disease Activity after Fingolimod Treatment Author: Ebrahimkhani S, Beadnall HN, Wang C, Suter CM, Barnett MH, Buckland ME, Vafaee F Journal: Mol Neurobiol. 2020 Feb;57(2):1245-1258. Description: we sought the possible utility of serum exosome microRNAs as biomarkers for disease activity in multiple sclerosis patients in response to fingolimod therapy.